StockpollyBeta
ChatSearch/
Get AppSign in
Menu
Sign in
CategoryChatSearchBlog
Markets
HeatmapScreener
Tools
P/E Compare
Company
AboutPricing
ContactFeedback
AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions
momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks
PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12
Popularity #4,784
ZYBT · NASDAQ · Drug Manufacturers - Specialty & Generic

Zhengye Biotechnology (ZYBT)

ZYBT

Develops veterinary vaccines for livestock and dogs in China.

$1.30
vs last close−0.05 (−3.70%)
OverviewEarningsFinancialsOwnershipNews

News type

  1. Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

    GlobeNewsWireJul 21

  2. Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

    Globe News WireJun 4

  3. Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results

    PRNewsWireApr 28

  4. Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure

    GlobeNewsWireApr 6

  5. Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Declines By 36.7%

    Defense WorldMar 27

  6. Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders

    GlobeNewsWireFeb 10

  7. Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

    GlobeNewsWireMay 23, 2025

  8. Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option

    GlobeNewsWireJan 14, 2025

  9. Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

    GlobeNewsWireJan 8, 2025

  10. Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

    GlobeNewsWireJan 6, 2025

  11. Zhengye Biotechnology's Growth Slows As It Seeks U.S. IPO

    Seeking AlphaJan 12, 2024

β 1.24briefsthe tapeclosesdividendstranscriptswiresliquidityclosesminutesYoY +18%threadsTSLAthreadsthreadsmarginsafter-hrstranscriptsmomentumVIX 14.2minutesrumorsupgradesQ3estimatesnewsflowbuybacksPCEthreadsvolatility13Fnarrativesflowsmomentumdowngradesyield curvesDXYdowngradessessions52w hiheadlinesyield curvesdowngradessentimentvolatilityyield curvesrumorsβ 1.24volumesfuturesforecaststickerspre-mktforecastschatterliquidityEPS 4.12newsflownoisedrawdownsGOOGLupgradesconsensuswires8-KliquidityconsensuswhispersMSFTheadlinespositioningbriefsthreadsEPS 4.12guidanceminutesnewsflow+0.8%cyclesestimates+2.41%marginsmarginsthreads2s10sliquiditycyclesnarrativesrumorsbuybacksvolumesPMI 52.1cycleschatter2s10stranscriptsconsensusmargins
GDPclosesYoY +18%buybacksnewsflow13FrevisionsflowsT+1positioningrevisionsnewsflowconsensusvolumesfilingsAAPLfuturesYoY +18%futuresmarginsflowsvolatilityrevisionsDXYwhispersearnings callspositioningAVGOcatalystsyield curvesMETA10-Kconsensus
P/E 28.4catalystsspx 0dtecatalystsbid/askvolatilityheadlinesguidancedrawdowns
Stockpolly
An agent-based financial analysis engine for public markets.
© 2026 Stockpolly. All rights reserved.
Company
AboutPricing
Legal
TermsPrivacy
Support
ContactFeedback